AUNA trades 48.7% below Wall Street's consensus target of $7.63.
Last 12 months price action with 12-month analyst target path
The base valuation assumes AUNA achieves its forward estimates and maintains a stable P/E multiple of 1.7x. This scenario reflects the blended consensus of 1 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 20, 2026, Auna S.A. (AUNA) has a Wall Street consensus price target of $7.63, based on estimates from 1 covering analysts. With the stock currently trading at $5.13, this represents a potential upside of +48.7%. The company has a market capitalization of $380M.
Analyst price targets range from a low of $6.90 to a high of $9.00, representing a 28% spread in expectations. The median target of $7.00 differs from the mean, suggesting potential outlier estimates.
The current analyst consensus rating is Hold, with 0 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 0 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, AUNA trades at a trailing P/E of 5.7x and forward P/E of 1.7x. Analysts expect EPS to grow +222.1% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $0.87, with bear and bull scenarios of $0.55 and $1.15 respectively. Model confidence stands at 61/100, reflecting moderate uncertainty in projections.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
UHSUniversal Health Services, Inc. | $8.8B | $141.17 | $216.00 | +53.0% | Hold | 6.0x | 43 |
THCTenet Healthcare Corporation | $15.1B | $172.57 | $259.50 | +50.4% | Buy | 9.6x | 32 |
CYHCommunity Health Systems, Inc. | $426M | $3.02 | $2.93 | -3.0% | Hold | — | 37 |
HCAHCA Healthcare, Inc. | $83.9B | $375.17 | $504.73 | +34.5% | Buy | 12.4x | 46 |
RDNTRadNet, Inc. | $4.2B | $53.74 | $85.00 | +58.2% | Buy | 104.2x | 11 |
SGRYSurgery Partners, Inc. | $1.9B | $14.55 | $19.33 | +32.9% | Buy | 33.9x | 22 |
AMSFAMERISAFE, Inc. | $589M | $31.32 | $44.50 | +42.1% | Buy | 14.9x | 6 |
ACHCAcadia Healthcare Company, Inc. | $2.3B | $24.87 | $28.33 | +13.9% | Buy | 16.5x | 25 |
SEMSelect Medical Holdings Corporation | $2.1B | $16.54 | $17.75 | +7.3% | Hold | 13.6x | 14 |
ENSGThe Ensign Group, Inc. | $9.0B | $153.65 | $222.33 | +44.7% | Buy | 20.3x | 13 |
Quick answers to the most common questions about buying AUNA stock.
The consensus Wall Street price target for AUNA is $7.63, representing 48.7% upside from the current price of $5.13. With 1 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
AUNA has a consensus rating of "Hold" based on 1 Wall Street analysts. The rating breakdown is mixed, with 1 Hold ratings making up the largest segment. The consensus 12-month price target of $7.63 implies 48.7% upside from current levels.
With a forward P/E of 1.7003x, AUNA trades at a relatively low valuation. The consensus target of $7.63 implies 48.7% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $9 for AUNA, while the most conservative target is $6.9. The consensus of $7.63 represents the median expectation. Our quantitative valuation model projects a bull case target of $1 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
AUNA is lightly followed, with 1 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 0 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month AUNA stock forecast based on 1 Wall Street analysts shows a consensus price target of $7.63, with estimates ranging from $6.9 (bear case) to $9 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $1, with bear/bull scenarios of $1/$1.
Our quantitative valuation model calculates AUNA's fair value at $1 (base case), with a bear case of $1 and bull case of $1. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 61/100.
AUNA trades at a forward P/E ratio of 1.7x based on next-twelve-months earnings estimates compared to a trailing P/E of 5.7x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on AUNA, with a "Hold" consensus rating and $7.63 price target (48.7% upside). 0 of 1 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
AUNA analyst price targets range from $6.9 to $9, a 28% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $7.63 consensus represents the middle ground. Our model's $1-$1 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.